88
Participants
Start Date
April 14, 2022
Primary Completion Date
April 1, 2024
Study Completion Date
April 1, 2024
LOKELMA 5 GM Powder for Oral Suspension
Patients will use Lokelma supplementation on off-dialysis days (4 days/week) while receiving hemodialysis with 3.0 K+/2.5 Ca++ mEq dialysate bath. The individual starting dose will be 5.0 grams, and may be titrated weekly in 5.0 gram increments up to 15.0 grams to maintain K+ between 4.0 and 5.5 mEq/L.
Mountain Kidney & Hypertension Associates, Asheville
Georgia Nephrology DBA Georgia Nephrology Research Institute, Lawrenceville
Nephrology Associates of Northern Illinois and Indiana (NANI), Fort Wayne
Clinical Research Consultants, Kansas City
Balboa Research, La Jolla
Collaborators (1)
AstraZeneca
INDUSTRY
NephroNet, Inc.
OTHER